tiprankstipranks
Easton Pharmaceuticals (EAPH)
:EAPH
US Market

Easton Pharmaceuticals (EAPH) Income Statement

Compare
89 Followers

Easton Pharmaceuticals Income Statement

Last quarter (Q3 2023), Easton Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Easton Pharmaceuticals's net income was $0.00. See Easton Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.56M$ 378.59K
Gross Profit
$ 0.00$ 0.00$ 0.00$ 201.40K$ 106.91K
Operating Expenses
$ 0.00$ 0.00$ 188.54K$ 523.57K$ 231.13K
Depreciation and Amortization
$ 228.49K$ 236.56K$ 180.67K$ 316.41K$ 119.06K
EBITDA
$ 0.00$ 0.00$ -188.54K$ -323.17K$ 0.00
Operating Income
$ 0.00$ 0.00$ -188.54K$ -323.17K$ -124.23K
Other Income/Expenses
$ 0.00$ 0.00$ 0.00$ 0.00$ -45.00K
Pretax Income
$ 0.00$ 0.00$ -188.54K$ -323.17K$ -169.23K
Net Income
$ 0.00$ 0.00$ -188.54K$ -323.17K$ -169.23K
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
0.00 0.00 1.34B 1.34B 1.21B
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 1.34B 1.34B 1.21B
Currency in USD

Easton Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis